Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.27
Delayed Data
As of Apr 28
 +0.0034 / +1.28%
Today’s Change
0.20
Today|||52-Week Range
0.64
-24.01%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.27
Today’s open0.26
Day’s range0.26 - 0.28
Volume134,593
Average volume (3 months)257,588
Market cap$24.5M
Dividend yield--
Data as of 04/28/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...-0.03-4.23%
HTGMHTG Molecular Diagno...-0.15-5.00%
--Protea Biosciences G...-0.06-28.57%
OPGNOpGen Inc+0.00+0.14%
Data as of 04/28/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts

Partner Offers

Search for Jobs